<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1659574</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: Evaluation of a novel <italic>Aspergillus</italic> IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Yajie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3014729/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Huanhuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yujie</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yuanyuan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Yuchen</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Xiaomin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jiamei</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Jinjin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Su</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/983721/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University</institution>, <addr-line>Nanjing</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University</institution>, <addr-line>Suzhou</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Respiratory and Critical Care Medicine, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University</institution>, <addr-line>Nanjing</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Respiratory and Critical Care Medicine, Nanjing Jinling Hospital, Medical School, Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xin Su, <email xlink:href="mailto:suxinjs@163.com">suxinjs@163.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1659574</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Lu, Zhong, Wang, Sun, Li, Cai, Cai, Wang, Zhong and Su.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Lu, Zhong, Wang, Sun, Li, Cai, Cai, Wang, Zhong and Su</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front Cell Infect Microbiol" journal-id-type="nlm-ta" xlink:href="10.3389/fcimb.2025.1599425" ext-link-type="doi">A Correction on <article-title>Evaluation of a novel <italic>Aspergillus</italic> IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis</article-title> By Lu Y, Zhong H, Wang Y, Sun C, Li Y, Cai Y, Cai X, Wang J, Zhong J and Su X (2025). <italic>Front. Cell. Infect. Microbiol.</italic> 15:1599425. doi:&#xa0;<object-id>10.3389/fcimb.2025.1599425</object-id>
</related-article>
<kwd-group>
<kwd>acute invasive aspergillosis</kwd>
<kwd>subacute invasive aspergillosis</kwd>
<kwd>non-neutropenic patients</kwd>
<kwd>
<italic>Aspergillus</italic> IgG lateral flow assay</kwd>
<kwd>diagnosis</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="710"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Clinical Infectious Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The title of this article was erroneously given as: &#x201c;Evaluation of a novel aspergillus IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis&#x201d;. The correct title of the article is &#x201c;Evaluation of a novel <italic>Aspergillus</italic> IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis&#x201d;.</p>
<p>&#x201c;Zhu, R. Z., Cheng, J., Luo, Y., Qiu, W., Huang, J., Jiang, Y., et&#xa0;al. (2023b). Diagnostic</p>
<p>laboratory features and performance of an aspergillus IgG lateral flow assay in a chronic</p>
<p>pulmonary aspergillosis cohort. Microbiol. Spectr. 11, e0026423. doi: 10.1128/</p>
<p>spectrum.00264-23]&#x201d;was not cited in the article. The citation has now been inserted in the page 10, section <bold>4 Discussion</bold>, paragraph 5 and should read:</p>
<p>&#x201c;Zhu, 2023b&#x201d;</p>
<p>In the <bold>Abstract</bold>, The mistake was the non-uniform writing of &#x201c;vs.&#x201d;. This has been corrected to read: &#x201c;The level of plasma <italic>Aspergillus</italic> IgG LFA in the IA group was significantly higher than that in the control group (190.5 AU/mL vs 50.3 AU/mL, P &lt; 0.001)&#x201d;</p>
<p>1. Page 06, section <bold>3 Results</bold>, sub-section 3.3, paragraph 2</p>
<p>The mistake was the non-uniform writing of &#x201c;vs.&#x201d;.</p>
<p>&#x201c;Compared to the <italic>Aspergillus</italic> IgG ELISA with a cut-off value of 80 AU/mL, the <italic>Aspergillus</italic> IgG LFA had equivalent sensitivity (65.1% vs. 69.8% for sensitivity, P = 0.549), but significantly higher specificity (97.5% vs. 87.5% for specificity, P = 0.021)(Table&#xa0;5).&#x201d;</p>
<p>The correct statement is &#x201c;vs&#x201d;.</p>
<p>&#x201c;Compared to the <italic>Aspergillus</italic> IgG ELISA with a cut-off value of 80 AU/mL, the <italic>Aspergillus</italic> IgG LFA had equivalent sensitivity (65.1% vs 69.8% for sensitivity, P = 0.549), but significantly higher specificity (97.5% vs 87.5% for specificity, P = 0.021)(Table&#xa0;5).&#x201d;</p>
<p>2. Page 06, section <bold>3 Results</bold>, sub-section 3.4</p>
<p>The mistakes were the non-uniform writings of &#x201c;vs.&#x201d; and &#x201c;to&#x201d;.</p>
<p>&#x201c;The ROC curves of <italic>Aspergillus</italic> IgG LFA had no significant differences between patients with acute and subacute IA (AUC0.812[95% CI: 0.705, 0.919] vs 0.874 [95% CI: 0.780 to 0.967], P =0.401)(Figure&#xa0;3D). The sensitivities, PPVs and NPVs of the <italic>Aspergillus</italic> IgG LFA were equivalent between patients with acute and subacute IA (57.6% vs. 73.3% for sensitivity, P = 0.190; 90.5% vs. 91.7% for PPV, P = 1.000; 84.8% vs. 90.7% for NPV, P =0.231)(Table&#xa0;5).&#x201d;</p>
<p>The correct statements are &#x201c;vs&#x201d; and &#x201c;,&#x201d;.</p>
<p>&#x201c;The ROC curves of <italic>Aspergillus</italic> IgG LFA had no significant differences between patients with acute and subacute IA (AUC0.812[95% CI: 0.705, 0.919] vs 0.874 [95% CI: 0.780, 0.967], P =0.401)(Figure&#xa0;3D). The sensitivities, PPVs and NPVs of the <italic>Aspergillus</italic> IgG LFA were equivalent between patients with acute and subacute IA (57.6% vs 73.3% for sensitivity, P = 0.190; 90.5% vs 91.7% for PPV, P = 1.000; 84.8% vs 90.7% for NPV, P =0.231)(Table&#xa0;5).&#x201d;</p>
<p>3. Page 09, section <bold>4 Discussion</bold>, paragraph 2</p>
<p>The mistake was the wrong writing of &#x201c;65.1%&#x201d;.</p>
<p>&#x201c;In this study, the sensitivity and specificity of the BALF GM were 65.1% and 90.0%, respectively (Table&#xa0;6).&#x201d;</p>
<p>The correct statement is &#x201c;65.0%&#x201d;.</p>
<p>&#x201c;In this study, the sensitivity and specificity of the BALF GM were 65.0% and 90.0%, respectively (Table&#xa0;6).&#x201d;</p>
<p>4. Page 09, section <bold>4 Discussion</bold>, paragraph 2</p>
<p>The mistakes were the non-uniform writings of &#x201c;vs.&#x201d; and &#x201c;<italic>P</italic>&#x201d;.</p>
<p>&#x201c;A meta-analysis showed that PCR had higher sensitivity for the diagnosis of IA in non-neutropenic patients such as COPD, solid tumors and autoimmune diseases with prolonged corticosteroid therapy, compared to those with HM and/or HSCT/SOT (88% vs. 68%, <italic>P</italic> &lt; 0.001) (Han et&#xa0;al., 2023).&#x201d;</p>
<p>The correct statements are &#x201c;vs&#x201d; and &#x201c;P&#x201d;.</p>
<p>&#x201c;A meta-analysis showed that PCR had higher sensitivity for the diagnosis of IA in non-neutropenic patients such as COPD, solid tumors and autoimmune diseases with prolonged corticosteroid therapy, compared to those with HM and/or HSCT/SOT (88% vs 68%, P &lt; 0.001) (Han et&#xa0;al., 2023).&#x201d;</p>
</body>
<back>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>